Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$212K Buy
2,332
+2,091
+868% +$191K 0.02% 221
2026
Q1
$2.34K Sell
241
-59
-20% -$6.66K 0.04% 175
2025
Q4
$2.4K Sell
300
-2,833
-90% -$361K 0.04% 168
2025
Q3
$420K Sell
3,133
-65
-2% -$8.53K 0.06% 143
2025
Q2
$435K Sell
3,198
-6,670
-68% -$880K 0.06% 133
2025
Q1
$1.31M Buy
9,868
+5,028
+104% +$640K 0.24% 75
2024
Q4
$547K Buy
4,840
+8
+0.2% +$924 0.1% 132
2024
Q3
$551K Buy
4,832
+2
+0% +$219 0.11% 117
2024
Q2
$502K Sell
4,830
-3,505
-42% -$372K 0.09% 128
2024
Q1
$947K Buy
8,335
+789
+10% +$90.4K 0.15% 101
2023
Q4
$831K Buy
+7,546
New +$754K 0.17% 87

Other funds holding ABT

LM Advisors's ABT Position: Q2 2026 in Review

LM Advisors increased its Abbott (ABT) stake by 868% in Q2 2026, buying an estimated $191K and bringing the position to 2,332 shares worth $212K. The position accounts for 0.02% of the portfolio, ranked #221.

LM Advisors first reported a position in ABT in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.31M in Q1 2025. 2,965 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • LM Advisors held 2,332 shares of Abbott worth $212K as of Q2 2026.
  • LM Advisors bought 2,091 Abbott shares in Q2 2026, an estimated $191K.
  • Abbott made up 0.02% of LM Advisors's portfolio in Q2 2026, its #221 holding.
  • LM Advisors first reported a position in Abbott in Q4 2023 and has held it in 11 quarters since.
  • LM Advisors's Abbott position peaked at $1.31M in Q1 2025.
  • 2,965 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on LM Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.